Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...